NEW YORK, April 20, 2017 /PRNewswire/ --
IMAX Corporation (NYSE: IMAX) today reported first-quarter 2017 revenue of $68.7 million and net income attributable to common shareholders of $0.1 million, or $nil per diluted share. Adjusted net income attributable to common shareholders for the first quarter was $0.06 per diluted share, inclusive of a $0.02 per diluted share asset impairment charge related to a write-down on a documentary title within the film distribution business. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA as calculated in accordance with the Company's credit facility, please see the end of this press release.
"Building on our record signings in 2016, our momentum in the first four months of 2017 has continued at an extremely strong pace. Not only have we witnessed record signings to date, we have also seen exceptional box office performance from titles such as The Fate of the Furious, which did $30 million in its opening weekend in IMAX and broke numerous box office records including our biggest opening weekend ever in China," said IMAX CEO Richard L Gelfond. "We closed the first quarter with a 30-theatre deal with Bona and just recently announced a 40-theatre deal with Omnijoi and a 25-theatre deal with AMC-Odeon, bringing our year-to-date signings to a record 104 new theaters. Not only do these deals demonstrate our partners' continued optimism in the IMAX business, they also underscore the global diversity of our future expansion. For instance, the Odeon deal has strategic significance to us on several fronts: it opens up markets in Western Europe such as Germany, Italy and Spain and significantly increases the Company's exposure to Scandinavia, which historically has generated above-average box office per screen. These types of agreements are also important as they help facilitate increased awareness in underpenetrated markets, which ultimately drives exhibitor demand for additional IMAX theaters."
First-Quarter 2017 Results
During the quarter, the Company installed 15 theaters, of which 14 were for new theatre locations and one was an upgrade. The total IMAX theatre network consisted of 1,226 systems as of March 31, 2017, of which 1,121 were in commercial multiplexes. There were 524 theaters in backlog as of March 31, 2017, up 35% from the 388 in backlog as of Mar. 31, 2016. Year to date, as of April 20, 2017, there were 589 theaters in backlog, up 52% from the year-ago period.
Continuing the Company's record signings momentum from 2016, IMAX signed contracts for 39 theaters in the first quarter of 2017, headlined by a 30-theatre agreement with Bona Film Group, a leading film distributor and vertically integrated film production company in China. Year to date, the Company has signed contracts for 104 new theatre systems. On April 11 the Company announced a 25-theatre agreement with Odeon Cinemas Group including its Nordic Cinema Group subsidiary, both wholly owned by AMC (NYSE:AMC), and the largest cinema operators in Europe. On April 18 the Company also announced a 40-theatre agreement with Omnijoi Cinemas, the third-largest IMAX exhibitor partner in China, and the fifth-largest globally. For a breakdown of theatre system signings, installations, network and backlog by type for the first quarter of 2017, please see the end of this press release.
"In addition to significantly expanding our network and backlog, we are beginning to execute against several new promising business initiatives," CEO Richard L. Gelfond continued. "We launched our flagship IMAX VR Centre in Los Angeles, announced our first-ever Hollywood VR slate deal with Warner Bros., and kicked off production with Marvel and ABC Studios on Marvel's Inhumans, which will debut exclusively in IMAX theaters in early September. We're encouraged by the progress we're seeing across these fronts and believe 2017 will serve as a key inflection point for IMAX as our business expands beyond box office."
Box Office Update:
Gross box office from IMAX DMR® titles was $212.1 million in the first quarter of 2017, compared with $272.0 million in the prior-year period. The average global DMR box office per-screen average in the first quarter of 2017 was $189,300, compared with $284,400 in same period last year. The first-quarter 2016 film slate comparisons included Star Wars: The Force Awakens carryover, Batman v Superman and Deadpool. Other upcoming tent-pole film releases include Guardians of the Galaxy Vol. 2, Transformers: The Last Knight, Spider-Man: Homecoming and Dunkirk.
First-Quarter Segment Results
Gross margin across all segments in the first quarter of 2017 was 52.1%, compared with 56.6% in the first quarter of 2016, mainly due to lower box office performance and the $3.4 million write-down in our film distribution business. Excluding the write-down, consolidated gross margin would have been 57.1% in the first quarter. Operating expenses (which include SG&A and R&D, and exclude stock-based compensation) were $30.0 million in the quarter, compared with $26.7 million in the first quarter of 2016, and consistent with guidance disclosed on the Q4 2016 call.
For more information about our results, please refer to the IMAX Investor Relations website located at www.imax.com/content/investor-relations
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company's investor community.
The information posted on the Company's website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its Twitter account in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
The Company will host a conference call today at 8:30AM ET to discuss its first-quarter 2017 financial results. To access the call via telephone, interested parties in the US and Canada should dial (800) 274-0251 approximately 5 to 10 minutes before the call begins. Other international callers should dial (416) 642-5209. The conference ID for the call is 7006877. A replay of the call will be available via webcast www.imax.com/content/investor-relations or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 7006877.
About IMAX Corporation
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of Mar 31, 2017, there were 1,226 IMAX theaters (1,121 commercial multiplexes, 14 commercial destinations and 91 institutions) in 75 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code "HK.1970."
This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the performance of IMAX DMR films; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; the Company's largest customer accounting for a significant portion of the Company's revenue and backlog; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company's inability to protect its intellectual property; risks related to the Company's implementation of a new enterprise resource planning system; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
For additional information please contact:
IMAX Corporation, New York
Sloane & Company, New York
Principal Communications Group, Los Angeles
Melissa Zuckerman/Paul Pflug
Signings and Installations
March 31, 2017
Ended March 31,
Full new sales and sales-type lease arrangements
New joint revenue sharing arrangements
Total new theaters
Upgrades of IMAX theater systems
Total Theater Signings
Total Theater Installations
As of March 31,
New sales and sales-type lease arrangements
Commercial Multiplex Theaters:
Sales and sales-type lease arrangements
Joint revenue sharing arrangements
Total Commercial Multiplex Theaters
Commercial Destination Theaters
Includes one installation of an upgrade to a laser-based digital system under sales arrangement (2016 – eight laser-based digital systems under sales and sales-type lease arrangements).
Includes one installation of an upgrade to a xenon-based digital system under sales arrangement.
Includes 21 laser-based digital theater system configurations, including three upgrades. The Company continues to develop and roll out its laser-based digital projection system.
Includes 21 laser-based digital theater system configurations, including six upgrades (one xenon configuration and five laser configurations).
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts)
Equipment and product sales
Costs and expenses applicable to revenues
Equipment and product sales
Selling, general and administrative expenses
(including share-based compensation expense of $5.3 million for the three months ended March 31, 2017 (2016 — expense of $5.9 million))
Research and development
Amortization of intangibles
Receivable provisions, net of recoveries
(Loss) income from operations
(Loss) income from operations before income taxes
Provision for income taxes
Loss from equity-accounted investments, net of tax
Net (loss) income
Less: net income attributable to non-controlling interests(1)
Net income attributable to common shareholders
Net income per share attributable to common shareholders - basic & diluted:
Net income per share – basic
Net income per share – diluted
Weighted average number of shares outstanding (000's):
Depreciation and amortization(2)
For the three months ended March 31, 2017, includes an adjustment of $1.9 million related to the Documentary Film Fund's non-controlling shareholder's portion of the impairment
Includes $0.1 million of amortization of deferred financing costs charged to interest expense for the three months ended March 31, 2017 (2016 - $0.1 million)
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars)
Cash and cash equivalents
Accounts receivable, net of allowance for doubtful accounts of $1,282 (December 31, 2016 — $1,250)
Property, plant and equipment
Deferred income taxes
Other intangible assets
Accrued and other liabilities
Commitments and contingencies
Capital stock common shares — no par value. Authorized — unlimited number.
66,596,784 issued and 66,573,078 outstanding (December 31, 2016 — 66,224,467 issued and 66,159,902 outstanding)
Less: Treasury stock, 23,706 shares at cost (December 31, 2016 — 64,565)
Accumulated other comprehensive loss
Total shareholders' equity attributable to common shareholders
Total shareholders' equity
Total liabilities and shareholders' equity
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended March 31,
Cash provided by (used in):
Adjustments to reconcile net (loss) income to cash from operations:
Depreciation and amortization
Write-downs, net of recoveries
Change in deferred income taxes
Stock and other non-cash compensation
Unrealized foreign currency exchange gain
Loss from equity-accounted investments
Loss (gain) on non-cash contribution to equity-accounted investees
Investment in film assets
Changes in other non-cash operating assets and liabilities
Net cash (used in) provided by operating activities
Purchase of property, plant and equipment
Investment in joint revenue sharing equipment
Investment in new business ventures
Acquisition of other intangible assets
Net cash used in investing activities
Repayment of bank indebtedness
Settlement of restricted share units and options
Common shares issued - stock options exercised
Treasury stock purchased for future settlement of restricted share units
Taxes withheld and paid on employee stock awards vested
Repurchase of common shares
Taxes paid on secondary sale and repatriation dividend
Net cash provided by (used in) financing activities
Effects of exchange rate changes on cash
Decrease in cash and cash equivalents during period
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
SELECTED FINANCIAL DATA
In accordance with United States Generally Accepted Accounting Principles
(in thousands of U.S. dollars)
The Company has four primary groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment and after-market sales of projection system parts and 3D glasses from the other segment; (3) New Business, which includes content licensing and distribution fees associated with the Company's original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items from the other segment.
Ended March 31,
Joint revenue sharing arrangements – contingent rent
IMAX systems - contingent rent
Sales and sales-type leases
Ongoing fees and finance income
Joint revenue sharing arrangements – fixed fees
Theater system maintenance
Film distribution and post-production
Joint revenue sharing arrangements – contingent rent(1)
Sales and sales-type leases(1)
Joint revenue sharing arrangements – fixed fees(1)
Film distribution and post-production(1)
IMAX DMR segment margins include marketing costs of $2.6 million for the three months ended March 31, 2017 (2016 - $2.3 million). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.4 million for the three months ended March 31, 2017 (2016 - $0.1 million). IMAX systems segment margins include marketing and commission costs of $0.4 million for the three months ended March 31, 2017 (2016 - $0.5 million). Film distribution and post production segment margins include a marketing recovery of $0.2 million for the three months ended March 31, 2017 (2016 – expense of $0.7 million) and an asset impairment charge of $3.4 million related to a write-down within the film distribution business.
Non-GAAP Financial Measures:
In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA and adjusted EBITDA as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.
The Company is required to maintain a minimum level of "EBITDA", as such term is defined in the Company's credit agreement (and which is referred to herein as "Adjusted EBITDA", as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that EBITDA and Adjusted EBITDA are relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry.
3 months ended
12 months ended
March 31, 2017(1)
(In thousands of U.S. Dollars)
Interest expense, net of interest income
Depreciation and amortization, including film asset amortization
Write-downs, net of recoveries including asset impairments and
Loss from equity accounted investments
Adjusted EBITDA before non-controlling interests
Adjusted EBITDA attributable to non-controlling interests(2)
Adjusted EBITDA attributable to common shareholders
Adjusted revenues attributable to common shareholders(3)
Adjusted EBITDA margin
Ratio of funded debt calculated using twelve months ended Adjusted EBITDA.
The Adjusted EBITDA calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company's non-controlling interests.
3 months ended March 31, 2017
12 months ended March 31, 2017
Greater China revenues
Non-controlling interest ownership percentage(4)
Deduction for non-controlling interest share of revenues
Adjusted revenues attributable to common shareholders
Weighted average ownership percentage for change in non-controlling interest share
Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended March 31, 2017 vs. 2016:
The Company reported a net loss of $0.9 million, or a loss of $0.01 per basic and diluted share for the first quarter of 2017, as compared to net income of $14.0 million or $0.20 per basic share and diluted share for the first quarter of 2016. Net income for the first quarter of 2017 includes a $5.3 million charge or $0.08 per diluted share (2016 — $5.9 million or $0.09 per diluted share) for stock-based compensation. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $3.0 million or $0.05 per diluted share for the first quarter of 2017, as compared to adjusted net income of $18.0 million or $0.26 per diluted share for the first quarter of 2016. The Company reported net income attributable to common shareholders of $0.1 million, or $nil per basic and diluted share for the first quarter of 2017 (2016 — $11.3 million, or $0.16 per basic and diluted share). Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $3.9 million or $0.06 per diluted share for the first quarter of 2017, as compared to adjusted net income attributable to common shareholders of $15.3 million or $0.22 per diluted share for the first quarter of 2016. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:
Quarter Ended March 31,
Reported net (loss) income
Tax impact on items listed above
Adjusted net income
Net loss (income) attributable to non-controlling interests
Stock-based compensation (net of tax of less than
$0.1 million and less than $0.1 million, respectively) attributable to non-controlling interests
Adjusted net income attributable to common shareholders
Weighted average diluted shares outstanding
Free Cash Flow:
Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:
Three months ended
Net cash used in operating activities
Net cash flow
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/imax-corporation-reports-first-quarter-2017-results-300442544.html
SOURCE IMAX Corporation
[ Back To NFVZone's Homepage ]